Unique features of epicardial ventricular arrhythmias/premature ventricular complexes ablated from coronary venous system in veteran population by Mar, Philip L. et al.
lable at ScienceDirect
Indian Pacing and Electrophysiology Journal 20 (2020) 97e104Contents lists avaiIndian Pacing and Electrophysiology Journal
journal homepage: www.elsevier .com/locate/ IPEJUnique features of epicardial ventricular arrhythmias/premature
ventricular complexes ablated from coronary venous system in
veteran population
Philip L. Mar a, b, 1, Mamta Barmeda b, c, *, Marcelle A. Stucky a, b,
Subodh R. Devabahktuni a, b, Jason Garlie a, John M. Miller a, Rahul Jain a, b
a Department of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA
b Roudebush Veterans Affairs Medical Center, Indianapolis, IN, USA
c Indiana University Health, Indianapolis, IN, USAa r t i c l e i n f o
Article history:
Received 3 February 2020
Accepted 13 February 2020
Available online 18 February 2020
Keywords:
Premature ventricular complex
Ventricular arrhythmias
Radiofrequency ablation
Coronary venous systemAbbreviations: CVS, coronary venous system; PVC
plexes; VA, Ventricular arrhythmia; VT, Ventricular t
ology; LVEF, Left ventricular ejection fraction.
* Corresponding author. Indiana University Health
Indianapolis, IN, 46217, USA.
E-mail address: mbarmeda@iuhealth.org (M. Barm
Peer review under responsibility of Indian Heart
1 MB and PM contribution is equal in the manuscr
https://doi.org/10.1016/j.ipej.2020.02.001
0972-6292/Copyright © 2020, Indian Heart Rhythm S
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Introduction: Ventricular arrhythmias/premature ventricular complexes (VA/PVCs) that can be ablated
from within the coronary venous system (CVS) have not been described in the United States Veterans
Health Administration (VHA) population. We retrospectively studied the VA/PVCs ablations that were
performed in the VHA population.
Methods: Data from 42 consecutive patients who underwent VA/PVCs ablation at Veterans Affairs
Hospital, Indianapolis, IN, with 44 VA/PVCs was included in the study. Patients were divided into two
groups (CVS group [n ¼ 10], and non-CVS group [n ¼ 32]) based on where the earliest pre-systolic
activation was seen with >95% pacematch.
Results: The mean age in CVS group was 65 ± 8 years versus 64 ± 12 years (p ¼ 0.69) in non-CVS group.
Overall there was a statistically significant reduction in PVC burden post ablation (27.7% (pre-ablation)
versus 4.7% (post-ablation). In the 10 patients in the CVS group, either ablation or catheter-related
mechanical trauma resulted in complete (n ¼ 6 [60%]) or partial (n ¼ 4 [40%]) long-term suppression
of VA/PVCs. Right bundle branch block-type VA/PVC (9/11: 82%) was the most common morphology in
the CVS group, whereas in the non-CVS group, this type was seen in only 3/33 (9%). The CVS group (25%
of total VA/PVCs) had shorter activation time compared to non CVS group.
Conclusion: In our experience VA/PVCs with electrocardiograms suggestive of epicardial origin can often
be safely and successfully ablated within the coronary venous system. These arrhythmias have unique
features in Veterans patient population.
Copyright © 2020, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mapping and ablation of ventricular arrhythmias (VA; non-
sustained or sustained ventricular tachycardia [VT] or fibrillation
(VF) or premature ventricular complexes (PVCs) from within the, Premature ventricular com-
achycardia; EP, Electrophysi-
, 8820 S Meridian, Suite 215,
eda).
Rhythm Society.
ipt.
ociety. Production and hosting bycoronary venous system (CVS) has previously been described in the
literature. The prevalence of VA/PVCs with earliest activation
localized to the CVS among all other VA/PVCs varies in the literature
from 9% to 15% [1e5] and the success rate among those who
received ablation within the CVS also varies between 36% to nearly
100% in smaller studies [5e8]. Ablation from within the CVS poses
significant potential risk, with complications include venous
perforation, damage to adjacent coronary arteries or the phrenic
nerve [7,9,10]. Nevertheless, the CVS is a valuable site for mapping
VA/PVCs, especially those arising from the right or left ventricular
outflow regions and in the portion of the left ventricle (LV) known
as the LV summit, where ablation success is limited due to need for
epicardial access as well as presence of epicardial fat and proximity
to coronary arteries and phrenic nerve [4e6,11].Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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in the American Veteran Health Administration (VHA) patient
population. This population is unique because of overall poorer
health and more comorbid medical conditions, compared to the
general population. The purpose of the present study is to report
the experiencewith catheter ablation of VA/PVCs at a single-center,
VHA hospital and describe the prevalence and electrophysiologic
characteristics of VA/PVCs localized to the CVS, along with out-
comes of ablation within the CVS.
2. Methods
2.1. Study population
The study population included veterans who underwent cardiac
electrophysiology (EP) procedures for evaluation and treatment of
ventricular arrhythmias (non-sustained or sustained ventricular
tachycardia or fibrillation) or premature ventricular complexes at
Roudebush Veterans Affairs Hospital, Indianapolis, IN. There were
42 patients who underwent EP procedures for this indication from
April 2015 until December 2018. Of these, 2 had more than one
morphology of clinical (spontaneously-occurring) PVC/VA; thus, a
total of 44 VA/PVCs were included in this study. In two cases no
ablation was performed because of the arrhythmia source’s prox-
imity to a major coronary artery. Both of these cases have been
included in final analysis.
Among the 44 VA/PVCs, 11 had origins mapped to within the
coronary venous system. All patients had echocardiogramwith left
ventricular ejection fraction (LVEF) estimation prior to the pro-
cedure; all but 6 had long-term ambulatory ECG monitoring priorFig. 1. Corornary sinus venogram done in a case where site of earliest activation was in m
2A: Shows coronary sinus venogram with decapolar bidirectional catheter inside the coron
2B: Shows ablation catheter (4) in middle cardiac vein
2C: Shows mechanical pressure resulted in suppression of the PVCs. In this case site with
1: Decapolar bidirectional coronary sinus catheter, 2: Quadripolar deflectable catheter positi
Coronary sinus, MCV: middle cardiac vein, Sheath: SR0 sheath used for venogram.to the procedure for quantification of PVC burden. All patients were
symptomatic from their arrhythmia. Of the 6 patients who did not
have long-term ambulatory ECG monitoring prior to their proced-
ure, 5 had ablation for ventricular tachycardia and one for ven-
tricular fibrillation initiated by PVC. All patients with VA/PVCs
localized in the CVS had pre-procedure ambulatory ECG moni-
toring. Post-ablation ambulatory monitoring was not done in 11 of
the 42 patients, among whom 6 did not have pre procedure PVC
quantification data.
2.2. Electrophysiological studies
The electrophysiological study was performed in patients in the
fasting state and all antiarrhythmic medications were stopped at
least 5 half-lives prior to procedure except for Amiodarone which
was stopped two weeks prior to elective procedure. Conscious
sedation or general anesthesia was used based on individual pa-
tient’s comfort level. Surface ECG and intracardiac recordings were
made on a CardioLab system (GE Medical, Milwaukee, WI, USA).
Surface electrocardiographic (ECG) leads were placed in the stan-
dard positions and recorded simultaneously using a digital multi-
channel system, filtered to 30e400 Hz for bipolar signals and
0.05e400 Hz for unipolar electrograms. A 3.5 mm ablation catheter
(ThermoCool®, force-sensing, Biosense Webster, Irvine, CA, USA)
was used for mapping and ablation. In a few cases, a 7F PentaRay®
catheter (Biosense-Webster, Irvine, CA, USA) was also used for
mapping. Three-dimensional activation mapping of arrhythmias
was performed using the CARTO system (Biosense-Webster, Irvine,
CA, USA). An 8Fr phased array, intracardiac echocardiography (ICE)
catheter (SOUNDSTAR®, Biosense-Webster, Irvine, CA, USA) wasiddle cardiac vein.
ary sinus and SR0 sheath used for venogram.
earliest activation and successful ablation was in the middle cardiac vein.
oned at His, 3: Quadripolar deflectable catheter positioned at base of right ventricle. CS:
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and catheter positioning. In all cases a detailed ultrasound-based
map was made for right ventricular (RV) body, left ventricle (LV),
right ventricular outflow tract (RVOT), aortic sinuses of Valsalva
and aortic root. The ablation catheter was used to make anatomical
map of the coronary venous system. A 6Fr deflectable quadripolar
catheter was placed in the right ventricle apical septum and
another at the His position. Heparin was administered intrave-
nously as boluses to maintain the activated clotting time between
250 and 300 s. For patients with infrequent PVCs at the time of the
study, an infusion of isoproterenol was started and titrated to effect.
A left coronary arteriogramwas performed in both the right and left
anterior oblique views prior to any ablation within the CS to ensure
no major coronary arteries were within 4 mm [12] of the site of
planned ablation. Whenever considered necessary, a coronary si-
nus venogram was performed (Fig. 1).Fig. 2. Intracardiac electrograms in a case with site of earliest activation in distal Coronary
The near field earliest electrograms was 24 ms earlier than the PVC QRS onset. The unipola2.3. Radiofrequency ablation
Earliest QRS onset on the twelve lead ECG was used as the
reference for mapping. Activation timing was measured from the
sharpest ventricular deflection of the catheter/electrode of interest
to the earliest deflection on the ventricular signal of the surface ECG
(Fig. 2). Pace mapping of PVCs was performed at a pacing cycle
length equal to the spontaneous VTor at the coupling interval of the
spontaneous PVCs [13] (Fig. 3).
Radiofrequency ablation was performed at the site of earliest
activation and >95% pace match with the 3.5 mm ablation catheter.
When the site of earliest activation was localized to the CVS, a left
coronary arteriogram was performed to assess the distance of the
catheter tip to a major epicardial coronary artery (Fig. 4). If this
distance was <4 mm, ablation was not performed (2 patients). In
one case, the site of earliest activation was 2.5 mm from the leftvenous system.
r electrograms shows a QS pattern and starts earlier than bipolar electrograms.
Fig. 3. Pacing from the site with earliest activation has been superimposed on the clinical PVC. It showed more than 95% pacematch.
P.L. Mar et al. / Indian Pacing and Electrophysiology Journal 20 (2020) 97e104100circumflex origin (Fig. 4). In the other case, the site of earliest
activation was 2 mm from the left anterior descending artery. To
avoid phrenic nerve injury, high output pacing was performed to
assess for diaphragmatic contraction when pacing at the site of
earliest activation. In none of the cases in which earliest activation
was found in the CVS was phrenic nerve capture demonstrated
with stimulation.
Radiofrequency energy was delivered at a power of 20e50W for
30e60 s. Impedance was monitored during RF delivery, that was
ceased in case of rapid impedance increase (100 U/3 s) or at anFig. 4. Coronary arteriogram done in subject 134. Note the relative proximity of the ablation
and right (RAO) anterior oblique views; numbers in caption refer to viewing angles in deg
1: Ablation catheter, 2: Decapolar bidirectional coronary sinus catheter, 3: Left circumflex cimpedance value of 250 U. (using Stockert 70 RF Generator,
Stockert GmbH, Freiburg, Germany). Impedance change cut offs and
maximum impedance values in some cases were adjusted to opti-
mize minimal impedance changes to allow RF delivery and lowest
maximal impedance cut off to allow for safe and effective RF de-
livery. Thereafter, multiple short applications of energy were used
to avoid impedance increases.
Intracardiac echocardiography was used continuously to
monitor for developing pericardial effusion. After completion of
ablation, a 30e45 min waiting period ensued to monitor for PVCcatheter (marked 1) to the left circumflex coronary artery (marked 3) in both left (LAO)
rees.
oronary artery, 4: Left anterior descending coronary artery.
Table 1
Clinical characteristics of patient population.
Parameter Overall (N ¼ 40) CVS Group (N ¼ 11) Non CVS Group (N ¼ 33) P value
Age (years) 64 ± 11 66 ± 8.42 64 ± 12 0.70
Height (cm) 70 ± 3 71 ± 3 70 ± 3 0.65
Weight (pounds) 211 ± 54 223 ± 61 207 ± 52 0.40
BMI (kg/m2) 30 ± 6 31 ± 7 30 ± 6 0.41
Gender Males ¼ 41 (93%) Females ¼ 3 (7%) Males ¼ 11 (100%) Males ¼ 30 (91%) Females ¼ 3 (9%) 0.3
Race Caucasian ¼ 39 (89%) African American ¼ 5 (12%) Caucasian ¼ 11 (100%) Caucasian ¼ 28 (85%) African American ¼ 5 (15%) 0.10
LVEF (prior to ablation) % 40. ± 16 33 ± 14 43 ± 15 0.07
LVEF % (post ablation) N ¼ 31 51 ± 11 48 ± 13 52 ± 10 0.34
PVC burden (pre ablation) N ¼ 38 27 ± 13 26 ± 16 27 ± 12 0.84
PVC burden (post ablation) N ¼ 33 8 ± 6 4 ± 6 5 ± 7 0.86
Table 2
Procedural details in PVCs with sites of earliest activation within the coronary venous system versus not within the coronary venous system.
Parameters CVS Group (N ¼ 11) Non CVS Group (N ¼ 33) P value
Earliest Activation Time (ms) 19 ± 9 27 ± 14 0.08
Procedure Time (mins) 211 ± 27 218 ± 18 0.83
Fluoroscopy Time (mins) 24 ± 11 21 ± 16 0.56
Post Procedure PVC burden 4.4 ± 6 5 ± 7 0.86
Post Procedure LVEF (%) 48 ± 13 52 ± 10 0.34
Acute Procedural Success 10/10 (100%) 28/33 (85%) 0.19
Coupling interval variation <60 ms 9 (82%) 23 (72%) 0.51
Data presented as mean ± standard deviation for continuous variables as as % for categorical variables.
Fig. 5. CARTO map showing ablation of a PVC in the coronary venous system.
CS: Coronary sinus
LV: Left ventricle
RCC: Right coronary cusp (aortic sinus of Valsalva)
The catheter with green tip in CS is the ablation catheter. The other catheter in CS is the decapolar bidirectional catheter.
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Fig. 6. A: 12 Lead Electrocardiogram showing premature ventricular complex with right bundle branch block type, right inferior axis morphology. The successful ablation site was in
the distal coronary venous sysetm.
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induce the targeted PVC at the end of the procedure. Complete long
term success was defined as reduction in clinical PVC burden
by  75% and partial long-term success as reduction in PVC burden
by < 75%.
2.4. Follow-up
All patients had post-procedure ECG and stayed in hospital
overnight while monitored on telemetry. Patients who were pre-
viously taking antiarrhythmic drugs including beta blockers were
not restarted on these at time of discharge. No immediate post
procedure complications were seen. Post ablation VA/PVCs burden
data was not available for 11 VA/PVCs.
2.5. Statistical analysis
Continuous data are expressed as mean ± SD. Means were
compared by use of Student’s t-test for paired data and 1-way
ANOVA when appropriate. Statistical analysis was performed with
the STATA/IC 13.010.0 statistical package (STATACorp LLC, College
Station, TX). A value of P < 0.05 was considered significant.
3. Results
3.1. Baseline characteristics
There were total of 42 patients. Two patients had two different
morphologies of VA/PVCs, giving a total of 44 VA/PVCs for final
analysis. The mean age in the overall study population was 64 ± 11
years with 93% male and 89% Caucasian. The earliest activationwas
seen in the CVS in 11 different VA/PVCs in 11 patients (25%).
The mean age in CVS group was 66 ± 8 years versus 64 ± 12
years (p ¼ 0.69) in the non-CVS group. The mean body mass index
(BMI) for the study population was 30 ± 6. The overall mean left
ventricular ejection fraction (LVEF) prior to the procedure was
43 ± 15%. The CVS group versus non-CVS group LVEF was 33 ± 5%
and 43 ± 3% respectively (p ¼ 0.05).
There was no statistically difference in the PVC burden pre-
procedure between the two groups (26% in CVS group and 27% in
non-CVS group, p ¼ 0.84). Overall there was a statistically signifi-
cant reduction in PVC burden post ablation (28%e5%, P < 0.005).
The PVC QRS duration in CVS group was 167 ± 4 ms versus
160 ± 6 ms in the non-CVS group (p ¼ 0.50) (Table 1).
3.2. Catheter ablation
In the CVS group, the earliest activation was 19 ± 9 ms prior to
QRS onset compared to 27 ± 14 ms in the non-CVS group (p ¼ 0.08)
(Table 2). Activation mapping was used in all CVS and non-CVS
patients (Fig. 5). As mentioned earlier, in two patients ablation
was not performed because of proximity of the site of earliest
activation to the major coronary arteries. In one such case, it was
noticed that catheter-tip pressure at the site with earliest activation
resulted in transient suppression of PVCs. Therefore, the distal
electrode of the ablation catheter was used to rub at that site. This
resulted in immediate suppression of PVCs and post-procedure
reduction in PVCs load from 27% to 5%. This reduction has per-
sisted in last 2 years of follow up.B: Electrocardiogram showing premature ventricular complex with right bundle branch blo
cardiac vein.
C: PVC from middle cardiac vein in cardiac electrophysiology laboratory with measuremen
PVC duration of 185 ms, QRS onset to peak of Lead V2 ¼ 101 ms, Pseudo-delta wave duration
185 ms ¼ 0.42. A majority of the measurements suggest an epicardial origin of the PVC.3.3. Sites of earliest activation in coronary venous system
In one patient the earliest activation was in middle cardiac vein
(MCV). In 10 VA/PVCs cases the site of earliest activation was in
distal portion of the coronary sinus and its branches. In one patient
there were two different morphologies of PVCs. For one
morphology the earliest activation was in the right aortic sinus of
Valsalva (SOV) and the second PVC had earliest activation in the
distal CS. However, it was not possible to position the ablation
catheter to the sitewith earliest activation in the CVS seen on the CS
catheter. Ablation in the right SOV resulted in complete suppres-
sion of PVC morphology from ROS as well as partial suppression of
the PVC from the CVS. Earliest electrograms were not seen with
percutaenous epicardial approach in the case. In the follow up
ambulatory ECGmonitor the overall PVC burden decreased from 39
to 19%. In the 10 patients in whom PVC/VA earliest activation site
was in the CVS and either ablation or mechanical rub was per-
formed, there was complete long-term suppression in 6/10, and
partial suppression in 4/10 PVCs/VA (in one patient neither rub nor
ablation was performed).
In the CVS group, the mean procedure time was 211 ± 27 min
compared to 218 ± 18 min in the non-CVS patients (p ¼ 0.83). Right
bundle branch block (RBBB)-type PVC (9/11: 82%) was the most
common morphology in CVS group, and 7/11 (64%) had RBBB, right
inferior axis morphology (Fig. 6). In the non-CVS group, this type
was seen in only 3/33 (9%). Sites closer to the junction of the
anterior interventricular vein and great cardiac vein had left bundle
branch block type instead of RBBB-type configuration.
4. Discussion
To our knowledge this is the first report of VA/PVCs ablation
from CVS at a Veterans Affairs Hospital. In our study population,
there was considerably greater percentage of patients with PVCs/
VA that had earliest activation in CVS (25%) compared to other
studies [4,5,13]. The reason for this is unclear but could be related to
our strategy of advancing the coronary sinus catheter almost to the
distal great cardiac vein and targeting earliest activation points
seen on this catheter. Another possible reason could be the unique
population, which has different comorbidities.
In our study we found a shorter time of earliest activation
(electrogram to QRS onset), 19 ± 9 ms compared to 27 ± 14 ms in
the non-CVS group. This is in contrast to earliest activation time of
29 ± 8 ms in CVS group seen in Baman et al. study [1]. Another
interesting finding was mechanical trauma with the catheter tip
resulting in suppression of PVCs without ablation. Both of these
points suggest that the site of origin in cases in which VA/PVCs can
be ablated from the CVS are very superficial in the vein or nearby
epicardium. This could result in higher success rates and fewer
complications compared to using a percutaneous epicardial
approach. The mechanism of catheter-tip trauma resulting in sup-
pression in one case has been described earlier and involves
alteration in the electrophysiological characteristics of tissue with
mechanical pressure [14]. Earlier studies have shown its benefits
for localization of points of interest in ventricular and supraven-
tricular arrhythmias [15,16]. However, there is no long-term data on
the effect of mechanical suppression as the only mode of therapy.
We report a single case in which we have long term data for pure
mechanical suppression of PVC. This phenomenon of mechanicalck type, right superior axis morphology. The successful ablation site was in the middle
ts.
¼ 50 ms, RS duration of 138 ms, precordial maximum deflection index (MDI) ¼ 78 ms/
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cases RF ablation was subsequently performed.
Overall there was statistically significant improvement in LVEF
post procedure (p ¼ 0.01). This finding is consistent with prior
reports where the lowest PVC burden of 10,000 per day, or 10%
showed reversible cardiomyopathy with ablation [17,18]. Previous
publications have shown reduction of PVC burden by 80% can result
in improvement in LVEF [19].
4.1. Study limitations
The study has number of limitations. The sample size is small.
This is a single center, single operator (RJ) study. However, ven-
tricular arrhythmia ablations are not performed universally at
Veterans Affairs hospitals. Therefore, it provides an insight into
these arrhythmias in this unique population.
5. Conclusions
In patients in whom ECG features suggest epicardial origin of
VA/PVCs, a coronary sinus catheter positioned in the distal great
cardiac vein can suggest if the arrhythmia can be ablated from
coronary venous system. In our experience with this distinct pa-
tient group, VA/PVCs with ECGs suggestive of epicardial origin can
be safely and successfully ablated within the coronary venous
system.
These arrhythmias have unique features in Veterans that have
not been reported in other patient population.
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